NCT02385721View on ClinicalTrials.gov

Post-Authorization Long-term Safety Surveillance on Antihypertensive Treatment With Kanarb® (Fimasartan)

CompletedOBSERVATIONAL
Enrollment

601

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

July 31, 2017

Study Completion Date

April 30, 2018

Conditions
Essential Hypertension
Trial Locations (1)

Unknown

Yoon Jun Kim, Seoul

Sponsors
All Listed Sponsors
lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY